These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33605146)

  • 1. Nanomedicine for Drug Delivery throughout the Alimentary Canal.
    Cote B; Rao D; Alani AWG
    Mol Pharm; 2022 Aug; 19(8):2690-2711. PubMed ID: 33605146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery.
    Moss DM; Curley P; Kinvig H; Hoskins C; Owen A
    Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):223-236. PubMed ID: 29088978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.
    Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA
    Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: Revolutionizing the Science of Drug Delivery.
    Mishra M; Kumar P; Rajawat JS; Malik R; Sharma G; Modgil A
    Curr Pharm Des; 2018; 24(43):5086-5107. PubMed ID: 30727873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease.
    Chen C; Beloqui A; Xu Y
    Adv Drug Deliv Rev; 2023 Dec; 203():115117. PubMed ID: 37898337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
    Bhattacharjee S; Brayden DJ
    Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine and drug delivery systems in cancer and regenerative medicine.
    Garbayo E; Pascual-Gil S; Rodríguez-Nogales C; Saludas L; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1637. PubMed ID: 32351045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of nanoparticle-based systems for the systemic delivery of chemotherapeutics: Alternative potential routes via sublingual and buccal administration for systemic drug delivery.
    Bahrami K; Lee E; Morse B; Lanier OL; Peppas NA
    Drug Deliv Transl Res; 2024 May; 14(5):1173-1188. PubMed ID: 38151650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
    Ozeki T; Tagami T
    Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
    Milane L; Amiji M
    Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine-based commercial formulations: current developments and future prospects.
    Thapa RK; Kim JO
    J Pharm Investig; 2023; 53(1):19-33. PubMed ID: 36568502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview on the current status of cancer nanomedicines.
    Jabir NR; Anwar K; Firoz CK; Oves M; Kamal MA; Tabrez S
    Curr Med Res Opin; 2018 May; 34(5):911-921. PubMed ID: 29278015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in self-assembled nanotechnology in tumor therapy.
    Kuang Y; Li Z; Chen H; Wang X; Wen Y; Chen J
    Colloids Surf B Biointerfaces; 2024 May; 237():113838. PubMed ID: 38484445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New challenges in the use of nanomedicine in cancer therapy.
    Rasool M; Malik A; Waquar S; Arooj M; Zahid S; Asif M; Shaheen S; Hussain A; Ullah H; Gan SH
    Bioengineered; 2022 Jan; 13(1):759-773. PubMed ID: 34856849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery.
    Vllasaliu D; Thanou M; Stolnik S; Fowler R
    Expert Opin Drug Deliv; 2018 Aug; 15(8):759-770. PubMed ID: 30033780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.
    Zierden HC; Josyula A; Shapiro RL; Hsueh HT; Hanes J; Ensign LM
    Trends Mol Med; 2021 May; 27(5):436-450. PubMed ID: 33414070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.